Insulet Corp. logo
PODDInsulet Corp.

Debt to Equity Ratio: 0.73

popular:market cap|pe ratio|revenue|price history|total return

Is the debt to equity ratio high or low?

The debt to equity ratio of 0.73 is 64% below its 5-year average of 1.99, near the low end of its 5-year range (0.69–3.34).

As of Thursday, June 25, 2026. 17.47% below its 12-month average of 0.88.

Current Ratio|Quick Ratio|ROE|All Metrics
Debt to Equity

PODD Debt to Equity Ratio

0.73

Reported quarterly debt to equity ratio; no daily interpolation.

-73.40% 5Y
PODD Debt to Equity Ratio

PODD Average Debt to Equity Ratio Chart

PODD Debt to Equity Ratio

PODD Current vs Average Debt to Equity Ratio Chart

PODD Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.73

DEBT TO EQUITY RATIO AVG TTM

0.88

DEBT TO EQUITY RATIO AVG 3Y

1.51

DEBT TO EQUITY RATIO AVG 5Y

1.99

DEBT TO EQUITY RATIO AVG 10Y

2.60

DEBT TO EQUITY RATIO AVG 15Y

2.38

DEBT TO EQUITY RATIO AVG 20Y

2.11

CURRENT VS TTM AVG

-17.47%

CURRENT VS 3Y AVG

-51.78%

CURRENT VS 5Y AVG

-63.51%

CURRENT VS 10Y AVG

-71.97%

CURRENT VS 15Y AVG

-69.45%

CURRENT VS 20Y AVG

-65.44%

PODD Competitors' Debt to Equity Ratio

NAMEMARKET CAPDEBT TO EQUITY RATIOTTM3Y5Y
Insulet Corp. (PODD)$10.31B0.730.881.511.99
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B3.232.451.881.68
Baxter International Inc. (BAX)vs ›$10.87B1.631.782.051.83
Charles River Laboratories International, Inc. (CRL)vs ›$9.73B0.970.880.910.99
Henry Schein, Inc. (HSIC)vs ›$9.55B1.140.990.790.64
Revvity, Inc. (RVTY)vs ›$11.78B0.480.450.510.56
Align Technology, Inc. (ALGN)vs ›$12.24B0.030.030.030.03
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.57B0.210.210.180.13
Oscar Health, Inc. (OSCR)vs ›$7.56B0.440.370.360.29
Solventum Corporation (SOLV)vs ›$13.09B1.001.851.110.74

Financial Health

Debt/Equity

0.73

Current Ratio

2.78

Debt to Equity Ratio Formula & Definition

Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Insulet Corp. (PODD)?
The debt to equity ratio for PODD stock is 0.73.
Is Insulet Corp.'s debt to equity ratio high or low?
The debt to equity ratio of 0.73 is 64% below its 5-year average of 1.99, near the low end of its 5-year range (0.69–3.34).
What is the TTM average debt to equity ratio for Insulet Corp. (PODD)?
The TTM average debt to equity ratio for PODD stock is 0.88.
What is the 3Y average debt to equity ratio for Insulet Corp. (PODD)?
The 3Y average debt to equity ratio for PODD stock is 1.51.
What is the 5Y average debt to equity ratio for Insulet Corp. (PODD)?
The 5Y average debt to equity ratio for PODD stock is 1.99.
What is the 10Y average debt to equity ratio for Insulet Corp. (PODD)?
The 10Y average debt to equity ratio for PODD stock is 2.60.
What is the 15Y average debt to equity ratio for Insulet Corp. (PODD)?
The 15Y average debt to equity ratio for PODD stock is 2.38.
What is the 20Y average debt to equity ratio for Insulet Corp. (PODD)?
The 20Y average debt to equity ratio for PODD stock is 2.11.

PODD Debt to Equity Ratio History

DATEDEBT TO EQUITY RATIO
2026-03-310.73
2025-12-310.69
2025-09-300.75
2025-06-300.97
2025-03-311.27
2024-12-311.17
2024-09-301.25
2024-06-301.40
2024-03-311.77
2023-12-311.98
2023-09-302.34
2023-06-302.52
2023-03-312.78
2022-12-313.01
2022-09-303.29
2022-06-303.34
2022-03-313.17
2021-12-312.31
2021-09-302.58
2021-06-302.74
2021-03-311.82
2020-12-311.78
2020-09-301.55
2020-06-301.62
2020-03-3115.24
2019-12-3111.94
2019-09-306.64
2019-06-302.47
2019-03-312.73
2018-12-312.79
2018-09-302.95
2018-06-303.22
2018-03-313.36
2017-12-313.57
2017-09-304.65
2017-06-305.27
2017-03-315.30
2016-12-315.27
2016-09-305.07
2016-06-306.49
2016-03-316.75
2015-12-315.21
2015-09-303.30
2015-06-302.57
2015-03-312.29
2014-12-312.02
2014-09-302.21
2014-06-302.59
2014-03-311.05
2013-12-310.98
2013-09-300.99
2013-06-300.82
2013-03-310.93
2012-12-312.67
2012-09-302.96
2012-06-302.37
2012-03-311.88
2011-12-311.52
2011-09-301.27
2011-06-301.11
2011-03-311.19
2010-12-311.05
2010-09-302.81
2010-06-302.10
2010-03-312.40
2009-12-311.83
2009-09-30316.51
2009-06-30-23.94
2009-03-315.27
2008-12-3119.89
2008-09-302.69
2008-06-301.66
2008-03-310.33
2007-12-310.29
2007-09-300.30
2007-06-300.27
2007-03-31-0.26
2006-12-31-0.29
2006-09-30-0.10
2006-06-300.00
2006-03-310.00
2005-12-31-0.15
2005-09-300.00
2005-06-300.00
2005-03-310.00

Related Metrics

Current RatioQuick RatioROEAll Metrics

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
www.insulet.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy
View full financials